Vir Biotechnology, Inc.
VIR
Revenue
3.08M
▼-53.30M▼-94.55%
3 Months ChangeAssets
1.67B
▼-124.41M▼-6.94%
3 Months ChangeLiabilities
235.89M
▼-10.73M▼-4.35%
3 Months ChangeFree Cash Flow
-111.26M
▲21.39M▲16.12%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001628280-24-044563
2024-09-10
Form 8-K
ID: 0001628280-24-039948
2024-08-01
Form 10-Q
ID: 0001628280-24-034195
2024-08-01
Form 8-K
ID: 0001628280-24-034143
2024-08-01
Form 8-K
ID: 0001193125-24-191500
2024-06-26
Form 8-K
ID: 0001193125-24-168554
2024-06-05
Form 8-K
ID: 0001193125-24-154636
2024-05-29
Form 8-K
ID: 0001193125-24-149139
2024-05-03
Form 10-Q
ID: 0001628280-24-020299
2024-05-02
Form 8-K
ID: 0001628280-24-020009